Both effects worsen semaglutide-related burping
Conclusion The intersection of GLP-1 weight loss medications and life insurance underwriting is creating new challenges for agents and clients alike
It is important to check if there are discounts or savings offer programs, such as the Ozempic savings card, from the pharmacy or the maker of the medicine
And although GLP-1 drugs have an overall favorable benefit-risk profile when appropriately prescribed, they are not benign: Gastrointestinal effects are common, discontinuation is frequent in real-world settings, and regulators continue to monitor rarer concerns including gallbladder disease, pancreatitis, aspiration risk, and psychiatric symptoms
Whether acquired through commercial sources or compounded formulations, these results validate its role as a very effective treatment option